Glenn Pierce: a short bio of the new WFH Vice President, Medical

Glenn Pierce – WFH Vice President, Medical, WFH USA Board Member and Vice President

Glenn Pierce, was elected to a four-year term as World Federation of Hemophilia (WFH) VP Medical this past May in Glasgow, Scotland. An active member the WFH, Pierce has already shared his thoughts on what it means to be a leader on the WFH board of directors, and what he would like to accomplish in his new role as VP Medical.

As a well-known figure in the bleeding disorders community for decades, one could say that Glenn Pierce needs no introduction—but for those who are new to the WFH, here is a short bio of our new VP Medical.

Glenn Pierce received his MD, PhD. (Immunology and Experimental Pathology) degree from Case Western Reserve University, in Cleveland, Ohio, U.S.A. As comfortable in the laboratory as in the corporate boardroom, Pierce has more than 30 years of research and development experience working with biotechnology companies. He is the co-author of more than 150 scientific papers and has over 15 patents to his name in tissue engineering, medical devices, clotting factors and viral vectors. Born with severe hemophilia A, Pierce was cured following a liver transplant in 2008.

He is currently entrepreneur-in-residence at Third Rock Ventures, where he is involved in new company ideation. Before joining Third Rock Ventures, Pierce worked for Biogen, where he led the development of the first extended half life clotting factors. He held various senior executive roles, including Senior Vice President of Hematology, Cell and Gene Therapies, Senior Vice President and Chief Medical Officer of Hemophilia, and Head of Global Medical Affairs.

Pierce has also been involved in the non-profit side of the medical community for a number of years. He served three terms as the President of the U.S.A National Hemophilia Foundation (NHF) in 1992, 1993 and in 2002. He has also served on the Medical and Scientific Advisory Council at NHF and the Blood Products Advisory committee at the Food and Drug Administration.

At Biogen, Pierce co-led the initiation of that company’s Humanitarian Aid Collaboration with the WFH. Humanitarian aid is a challenge Pierce is still very closely involved with, and the WFH Humanitarian Aid Program is one of the key endeavours he will help lead as our newest VP Medical.